$149.19 1.03 (+0.70%)
11/25/2009 4:00 PM

Alcon, Inc. (ACL)

CAPS Rating: 4 out of 5

The Company develops, manufactures and markets pharmaceuticals, surgical equipment and devices and consumer eye care products to treat diseases and disorders of the eye.

Results 1 - 20 of 56 1 2 3 Next »

Recs

0
Member Avatar JDKeene (92.63) Submitted: 11/19/2009 8:30:09 AM : Outperform Start Price: $146.26 ACL Score: +1.22

finviz.com

Recs

0
Member Avatar Nostradamuss (52.16) Submitted: 10/27/2009 7:15:23 PM : Outperform Start Price: $147.99 ACL Score: -4.12

Nice company

Recs

0
Member Avatar wooderino (89.91) Submitted: 10/27/2009 12:35:38 PM : Outperform Start Price: $142.20 ACL Score: +0.66

Showed up on a screen for solid 5 year growth with low debt, cash on hand and still at attractive P/E ratios.

Recs

0
Member Avatar richardrogers4 (64.87) Submitted: 8/17/2009 2:07:23 PM : Outperform Start Price: $126.30 ACL Score: +4.57

Defensive

Recs

0
Member Avatar gea1968 (91.43) Submitted: 8/4/2009 6:11:56 PM : Outperform Start Price: $131.60 ACL Score: +2.31

fundamentals and momentum; favorable StockScouter rating

Recs

0
Member Avatar TheBarnacle (79.07) Submitted: 5/1/2009 1:40:59 PM : Outperform Start Price: $88.86 ACL Score: +40.04

Intrinsic value of $259.38

Recs

0
Member Avatar BARB64Texas (< 20) Submitted: 3/12/2009 7:09:04 PM : Outperform Start Price: $83.30 ACL Score: +29.97

STELLAR INTERNATIONAL COMPANY-THEY HAVE BECOME INCREASINGLY DIVERSE MEETING HEALTHCARE NEEDS W/ MEDICINE, HIGH TECH EQUIPMENT--UNIQUELY BRILLIANT SCIENTIST, LEGAL TEAM, MARKETING---i HAVE FOLLOWED FOR 20 YEARS!

Recs

0
Member Avatar Jmcq88 (56.39) Submitted: 3/2/2009 9:46:25 PM : Outperform Start Price: $74.54 ACL Score: +41.74

New AcrySof IQ Toric IOL approved for U.S. patients with cataracts and astigmatism (ACL) 76.34 -6.02 : The co announces that the FDA approved its aspheric AcrySof IQ Toric intraocular lens (IOL). The new lens offers an enhanced aspheric optic that improves image quality and increases contrast sensitivity in cataract surgery patients with astigmatism. The innovative lens design offers these patients the best opportunity for quality distance vision without glasses.

Recs

0
Member Avatar RugbyViking13 (90.80) Submitted: 2/26/2009 2:26:09 PM : Outperform Start Price: $82.67 ACL Score: +33.27

Numbers all look great you cant beat stocks on a discount

Recs

0
Member Avatar edejeu (76.01) Submitted: 2/19/2009 9:25:55 PM : Outperform Start Price: $87.50 ACL Score: +22.73

They make a lot of cheaper necessities that people need and will use their products more because of their prices

Recs

0
Member Avatar steprightup (68.31) Submitted: 2/17/2009 9:20:31 PM : Outperform Start Price: $84.01 ACL Score: +35.54

can't say no at this price

Recs

0
Member Avatar thestinkyfeet (94.15) Submitted: 2/13/2009 2:17:54 AM : Outperform Start Price: $86.26 ACL Score: +37.23

The pitch for this stock can be found on the Stinky Feet bulletin board at http://boards.fool.com/Message.asp?mid=27429594 . Stop by and let us know what you think of this stock.

Recs

1
Member Avatar StockSpreadsheet (65.49) Submitted: 2/10/2009 10:10:12 PM : Outperform Start Price: $80.57 ACL Score: +53.14

My pitch for this stock can be found on the Stinky Feet bulletin board at http://boards.fool.com/Message.asp?mid=27429594 . Stop by and let me know what you think.

Recs

0
Member Avatar kevinottofro (98.71) Submitted: 2/9/2009 5:38:41 AM : Outperform Start Price: $78.43 ACL Score: +59.88

Low relative PE, good Caps, good PEG ... bottom fishing 2/9/09

Recs

0
Member Avatar valeryru (< 20) Submitted: 2/6/2009 10:39:38 PM : Underperform Start Price: $78.43 ACL Score: -59.88

ACL WAS GOOD BEFORE NESTLE DUMP 25%, NESTLE HAS VERY SMART MANAGEMENT WITH ALL THE TOOLS TO MAKE MONEY, WHEN MONEY HAS BEEN MADE, A SALE (DUMP) IS THE ONLY WAY OUT, THEN BY THIS TIME LOOK FOR THE NEXT NESTLE BUY, YOU WILL MAKE MONEY. REMEMBER "ACL" IPO $32.00 AND THE OVER $175.00 BEFORE THE 25% SALE AND OTHER DOWNLOADS.

LOOK OUT !!!!!

Recs

0
Member Avatar ChrisHallweaver (< 20) Submitted: 1/31/2009 4:29:34 PM : Outperform Start Price: $81.23 ACL Score: +44.61


Recs

1
Member Avatar traderpat9 (95.76) Submitted: 1/23/2009 5:49:14 PM : Outperform Start Price: $79.75 ACL Score: +51.47

THIS IS A GREAT PHARMACEUTICAL (I LOVE THESE KIINDS OF COMPANIES.) WITH LAZER SURGERY GROWING. THIS IS A GREAT BUY RIGHT NOW. BUY & HOLD!!!!!!!!!!!!

Recs

0
Member Avatar Speculator5252 (< 20) Submitted: 1/17/2009 2:35:56 PM : Outperform Start Price: $80.09 ACL Score: +51.71

Potential Stock for real portfolio

Recs

0
Member Avatar jimlanad (91.64) Submitted: 1/16/2009 5:08:03 PM : Outperform Start Price: $80.09 ACL Score: +51.71

A world leader in eye care eqpt. selling at > 30% below its fair value estimated at $128.00. Div. at 2.9%

Recs

0
Member Avatar foolontherocks (81.57) Submitted: 1/5/2009 5:32:40 PM : Outperform Start Price: $86.36 ACL Score: +51.66

everyone needs cataracts and corneas worked on...they also make ciprodex...the only ear drop medication out there that works for otitis externa

Results 1 - 20 of 56 1 2 3 Next »

Featured Broker Partners